GLP-1 Injections contain the same active ingredients found in name-brand injectable medications used for weight loss and diabetes management. These medications were originally FDA-approved in 2017 to treat type 2 diabetes, and later approved in 2021 for weight loss. Studies have shown that GLP-1 Injections can help patients lose an average of 15% of their body weight. The same active ingredients are used across medications, although dosing may vary.

GLP-1 Injections mimic a natural hormone called glucagon-like peptide-1 (GLP-1), which is produced in the gut. This hormone helps regulate appetite by signaling the brain to reduce hunger, slowing how quickly food leaves the stomach, and improving insulin release from the pancreas. Together, these effects support blood sugar control and sustained weight loss.

GLP-1 Injections have been shown to support long-term weight loss of up to 15%. Beyond weight management, patients may also see improvements in energy, sleep, and mood. Medical benefits can include reduced risk of heart disease, improved blood pressure, better blood sugar control, improved cholesterol levels, and support for liver and kidney health.

Most side effects are mild and temporary. These may include nausea, constipation, vomiting, or diarrhea—usually resolving within 2 to 3 weeks. Nausea is often considered an expected effect due to reduced appetite. Less common side effects can include allergic reactions, low blood sugar, gallstones, kidney issues (especially if dehydrated), and in rare cases, pancreatitis. Thyroid tumors have been observed in animal studies but not in humans.

GLP-1 Injections may not be suitable if any of the following apply:

You are pregnant or planning to become pregnant

You have a known allergy to GLP-1 medications or their ingredients

You have a personal or family history of medullary thyroid carcinoma

You have a personal or family history of multiple endocrine neoplasia syndrome type 2 (MEN 2)

Always consult with your healthcare provider to determine if GLP-1 therapy is right for you.

GLP-1 Injections are given under the skin, typically in the thigh, abdomen, or upper arm. You should rotate the injection site weekly to reduce irritation. Injections can be taken with or without food, at any time of day, but should be given on the same day each week. If you need to adjust your schedule, avoid injecting within two days of your last dose. If you miss a dose, take it within five days; otherwise, skip and resume your normal schedule.

GLP-1 medications are started at a low dose and gradually increased to improve tolerance and minimize side effects. A typical dosing schedule may look like this:

Month 1: 0.25 mg once weekly

Month 2: 0.5 mg once weekly

Month 3: 1.0 mg once weekly

Month 4: 1.7 mg once weekly

Month 5: 2.4 mg once weekly

Most patients remain on a maintenance dose of 1.7 mg or 2.4 mg, depending on their individual response and goals. Your provider will guide your dosing schedule based on clinical response and side effects.